Today’s AI Top Pick: WING

8/12/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted OversoldWINGBUY NOW8.7 / 108/12/2026

Wingstop is the cleanest set-up in this oversold pool: it combines the best fundamentals in the group with rare four-timeframe forecast agreement AND a deeply washed-out tape. Fundamental score of 6 is the highest here — 28.77% operating margin, 16.15% profit margin, 7.61% sales growth, 82.62% gross margin, PEG 1.18, fwd PE 20.78, analyst recom 1.47 (strong buy) and 87.5% consensus upside. That's a franchise-quality business, not a busted micro-cap. Yet RSI is 26.64, shares are down 66% YoY / 53% YTD, drawdown from the weekly 21-bar high is -42.87%, and position in the 21-bar range is 0-9.6% across every timeframe. This is what capitulation in a real compounder looks like. The forecast tape confirms: 1h fc_mid +21.1%, 4h fc_mid +45.9% / long +65.4%, 1d fc_short +32.6% / mid +83.4% / long +96.5%, 1wk fc_mid +47.1% / long +103.8%. All four timeframes agree, near_term_bullish = 1.0, kronos bullish_prob = 1.0. Unlike LDI/MBRX/BTCT where the huge forecasts are a math artifact of penny-stock volatility, WING's 1d/1wk numbers reflect a $3B market-cap name reverting from a genuine multi-quarter drawdown. News is the tiebreaker check and it doesn't derail the thesis. There's a bearish MarketBeat piece ('Growth Story Losing Steam') but it's counterbalanced by a Seeking Alpha 'Strong Buy' Aug 8, and the Q1 print is already in the price — that's how RSI got to 26. There's no guidance cut past what's baked in, no legal/dilution/short-report landmine. Compare that to POST (revenue miss + PT cut), PZZA (dividend suspended), UAA/UA (Barclays downgrade to Underweight), XPOF (guidance under pressure), EZPW (downgrade after 100%+ rally), or TDUP ('collapses on Q2') — WING has the fewest active landmines relative to signal quality. Why TODAY: position_in_21bar_range 0.48% (4h) and 1.54% (1d) means you're literally at the low, not chasing. Waiting risks missing the mean-reversion the 1d fc_short (+32.6% in ~1 month) is projecting. Sizing should reflect the -42% weekly drawdown — this is a mean-reversion trade in a bruised name, not a breakout.

Entry zone

$108–$114 (scale in around current $111.89; add on any flush to $105 which is prior support)

Stop loss

$99 close (below the psychological $100 and ~11% under entry; invalidates the base)

First target

$135–$140 (aligns with 1d fc_short +32.6% ≈ $148 discounted; near prior consolidation)

Longer target

$180–$205 (1d fc_mid $205, 1wk fc_mid $164 — 6-12 week swing objective)

Risks

Same-store sales deceleration — the Aug 10 'growth story losing steam' narrative could re-accelerate selling if next comp print misses
Valuation still not cheap in absolute terms: PE 26.44, PS 4.21 — if multiple compresses further, downside to $95 (~15%) is real
Short float 15.68% is the lowest in the pool — less short-squeeze fuel than PHAT (26.1%), BTDR (44.1%), or MBRX (33.7%)
1h fc_short is only +2.04% — very near-term the tape may chop before the 1d/1wk projections play out
Restaurant peer PZZA just cut its dividend and printed weak; sector sentiment is fragile and could pull WING lower in sympathy

Honorable mentions

PHATHighest expected mean reversion in healthcare with clean setup: 4h fc_mid +53%, 1d +38.9%, all TFs bullish, position 0-8.6% in range, salesYoY +110%, analyst recom 1.30, 157% target upside, 26% short float for squeeze fuel, and both Guggenheim and HC Wainwright reiterated Buy after Q2. Only knock is -41% profit margin — but this is a growth pharma, not a mature business.

MNROStrongest forecast magnitudes in the mid-cap group: 4h fc_long +71%, 1d fc_long +57%, 1wk fc_long +77%, all TFs bullish (near_term_bullish=1.0), position 0% in range on every TF, 88.7% target upside, 27.4% short float. Fundamentals thinner (PE 58, oper margin 2.29%) and news flow is soft ('market pressures persist'), so it's #3 not #1.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	WING	BUY NOW	8.7	Best fundamentals in the pool (FS=6, 28.8% op margin) + 4-TF forecast agreement + literal 21-bar low = highest-quality mean-reversion setup.
2	PHAT	BUY NOW	8.1	Clean multi-TF bullish, 26% short float, dual analyst Buy reiterations, 157% target upside — cleanest healthcare re-rate candidate.
3	MNRO	BUY NOW	7.6	Highest forecast magnitudes across TFs (+57/58/71% at 4h), position 0% in range, but fundamentals thinner than WING.
4	TRIP	BUY PULLBACK	6.8	Positive Airbnb partnership catalyst and 1wk fc_mid +45%, but 4h fc_mid is -3.8% suggesting near-term chop first.
5	BTDR	BUY PULLBACK	6.5	44% short float and Benchmark $22 target vs $8.89 spot, but weekly fc_long only +12% — waited best on flush.
6	POST	BUY PULLBACK	6.3	Solid 3-TF bullish forecasts and PE 14.4, but Q2 revenue miss and Barclays PT cut to $95 mean let the dust settle.
7	PZZA	BUY PULLBACK	6.0	Strong 4h/1d/1wk forecasts (+42-95%) but dividend suspension is a real overhang — wait for base.
8	GOGO	BUY PULLBACK	5.7	1wk fc_long +298% and 194% target upside, but earnings miss and only 15.1% short float.
9	LDI	WAIT	5.4	Enormous forecasts (+162% long) but $0.86 penny status and 22.93 debt/equity make this too fragile to size.
10	TTEC	WAIT	5.2	1d fc_long +108% but weekly fc is -15.5% — timeframes disagree, plus $84M cap and 12.93 debt/equity.
11	XPOF	WAIT	5.0	1wk fc_long +127% is enticing but 'execution and guidance under pressure' news undercuts the bounce thesis.
12	CHRS	WAIT	4.8	511% target upside and multi-TF bullish 4h/1d, but 1wk turns negative and -256% profit margin is scary.
13	TDUP	WAIT	4.6	1d fc_mid +89% but SA piece 'Collapses on Q2, further to fall' is a real landmine — sit this out.
14	PACB	WAIT	4.5	1wk fc_long +51.8% but SA 'It's Only Getting Worse' and -929% ROE. Broken until proven otherwise.
15	VERA	WAIT	4.4	168% target upside but weekly forecasts turn NEGATIVE (-12.9% long) and near_term_bullish=0. Wait.
16	ANGI	WAIT	4.3	1wk fc_long +175% but recent 'this isn't an AI company' and UBS PT cut show narrative is broken.
17	MPT	WAIT	4.2	Modest positive forecasts (+18% long 1d) but -3.1% profit margin, 2.16 D/E and recent -9.6% debt refi drop.
18	JBGS	WAIT	4.0	1d fc_mid +48% but analyst recom 5.0 (SELL) and Evercore Underperform reiterated — tape doesn't override that.
19	BTCT	WAIT	3.8	216% short forecast is BTC-mining volatility math; $4.76M cap is untradeable in size.
20	SG	WAIT	3.7	1wk fc_long +61% but two PT cuts in as many days (RBC $6.50, DA Davidson $5.50) — no rush.
21	COLM	WAIT	3.5	Fundamentals okay (PE 14.6) but forecasts modest (+29% long weekly only) and pos in range not extreme low.
22	MBRX	AVOID	3.0	4672% target and +720% 1d fc are math artifacts on a $3M cap; 1wk fc is -100%. Uninvestable.
23	UAA	AVOID	2.8	Barclays downgrade to Underweight with $5 PT vs $5.40 spot on Aug 12 kills the near-term bounce thesis.
24	UA	AVOID	2.7	Same Barclays downgrade applies; kronos_prob only 0.4.
25	ESTA	AVOID	2.5	Every timeframe forecast is NEGATIVE (-1 to -33%) and kronos_prob=0; JPM upgrade insufficient vs tape.
26	NTST	AVOID	2.3	All forecasts negative across TFs, kronos_prob=0, PE 141, PS 9.2 — screen match on paper only.
27	ABX	AVOID	2.0	All 1d forecasts negative (-7 to -15%), kronos_prob=0 despite decent fundamentals — tape says no.
28	EZPW	AVOID	1.8	SA 'Time to Take Profits' downgrade and 1wk fc_long -58% — this is a top, not a bottom.
29	DAVE	AVOID	1.5	1wk fc_long -61.6% and stock already +40% YTD, +66% YoY — this doesn't belong in an oversold screen.
30	SNBR	AVOID	0.5	$2.88M market cap, -98.5% YTD, stale July data — untradeable delisting risk.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord